Press Releases

Original 1543937948

Tuberculosis in the blood

December 06, 2018
By analyzing the chemicals in the blood, scientists can find out who develops active tuberculosis more
Original 1508158188
Emmanuelle Charpentier, director at the Max Planck Institute for Infection Biology in Berlin, is among the winners of the international renowned Kavli prize. She is honoured for her pioneering work in developing the CRISPR-Cas9 system, a breakthrough tool for genetic engineering. The award ceremony will take place in Oslo on September 4, 2018. more
Original 1300715086
In future, a blood test could identify which individuals with latent TB infection are at high risk of developing the disease more
Original 1522054145
VPM1002 is being trailed for efficacy and safety in patients with recurrent tuberculosis and in HIV-exposed newborns more
Original 1520853986
By extracting cholesterol from host cell membranes, Helicobacter pylori generates “micro-islands” more
Teaser image horizontal 1504272623
Max Planck scientists discover novel innate surveillance mechanism to fight off pathogenic Helicobacter strains more
Teaser image horizontal 1502885274
New mechanism of stomach gland regeneration reveals impact of Helicobacter pylori infection more
Vector Biology Unit at MPIIB joins the Infravec2 project: A European Commission 10M€ effort to fight mosquito-transmitted diseases

On February 14, the European Commission officially approved the Infravec2 project. This project will improve the European large-scale facilities (infrastructures) for research on mosquitoes and other insects (vectors) that carry human and animal diseases, and will promote sharing of the facilities by European researchers. more

Original 1527851023
For Emmanuelle Charpentier, deciphering the functioning of an enzyme previously known only to experts was a life-changing moment more
Teaser image horizontal 1462798310
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus more
Go to Editor View